Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency

British Journal of Pharmacology
D P Clough, R Hatton

Abstract

1 The purpose of this study was to investigate whether the separation between the hypotensive and sedative effects of a new series of centrally acting antihypertensive drugs was due to differences between the relative pre-junctional (alpha(2)) and post-junctional (alpha(1)) adrenoceptor agonist properties of the compounds.2 In anaesthetized rats the intravenous doses of clonidine, ICI 101187, ICI 106270, ICI 109683 and ICI 110802 required to lower blood pressure (BP) by 20 mm Hg were 1.2, 5.1, 5.5, 3.3 and 5.4 mug/kg respectively.3 In a test for sedation, ICI 101187 had at least 10 times less sedative effect than clonidine, ICI 106270 and ICI 109683 had at least 30 times less sedative effect than clonidine while ICI 110802 was not active. In a locomotor activity test the intravenous dose of clonidine required to reduce activity by 50% was 15.3 mug/kg, for ICI 101187 it was 194, for ICI 106270 it was 238 and for 110802 it was 313 mug/kg.4 In the pithed rat the ED(50)s of clonidine, ICI 101187, ICI 106270, ICI 109683 and ICI 110802 as alpha(2)-agonists were 19.4, 9.3, 63.2, 43.0 and 78.5 mug/kg respectively. The alpha(1)-adrenoceptor potencies were quite similar for the five drugs and varied between 3.2 mug/kg for ICI 110802 and ...Continue Reading

References

Oct 1, 1976·General Pharmacology·K Starke, T Endo
Dec 1, 1971·British Journal of Pharmacology·R B HolmanM Vogt
Jul 1, 1974·Biochemical Pharmacology·S Z Langer

❮ Previous
Next ❯

Citations

Aug 1, 1988·Early Human Development·M J BoutroyM Legagneur
Aug 21, 2003·Autonomic Neuroscience : Basic & Clinical·Teruyasu UmezawaTadashi Hisamitsu
Dec 1, 1990·Journal of Veterinary Pharmacology and Therapeutics·J C BrearleyR S Jones
Oct 1, 1995·Journal of Veterinary Pharmacology and Therapeutics·S SalonenM Anttila
Apr 1, 1986·Neuropharmacology·A G HayesM B Tyers
Aug 1, 1987·The International Journal of Neuroscience·R SandykC R Bamford
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·R R VollmerV S Murthy
Sep 1, 1986·Clinical and Experimental Pharmacology & Physiology·M P RechtmanW A Walters
Oct 1, 1982·British Journal of Clinical Pharmacology·B J Pleuvry, J B Redpath
Jan 20, 2021·Fundamental & Clinical Pharmacology·Michelle M MendonçaCarlos Henrique Xavier
Jan 1, 1994·Pharmacology & Therapeutics·R R Ruffolo, J P Hieble

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Clinical and Experimental Hypertension. Part B, Hypertension in Pregnancy
J S HorvathD J Tiller
British Journal of Clinical Pharmacology
J B Redpath, B J Pleuvry
Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society
V E CowlesS K Sarna
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association
Alessia DianaMario Cipone
Clinical and Experimental Dialysis and Apheresis
K Thurau
© 2021 Meta ULC. All rights reserved